Injectable Egg-Free Influenza Vaccine 2027
DLA Troop Support seeks an injectable egg-free influenza vaccine for the 2027-2028 flu season, approximately 300,000 prefilled-syringe doses for individuals 18 and older, under a proposed indefinite-quantity contract with a guaranteed minimum of 75% and maximum of 150% of the annual estimate. The vaccine must be FDA-approved and CDC/ACIP-recommended, with the 2027-2028 formula determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Deliveries will be to Defense Depot New Cumberland, PA, with a preferred schedule of 40% by August 12, 2027, 25% by August 26, 2027, 25% by September 9, 2027, and 10% by September 23, 2027; other schedules may be considered. The solicitation is projected for October 2026 and will be posted to DIBBS and SAM.gov. Interested parties may contact Rosbert Jones for questions or comments.